U-Blot® Research Grade SilevimigCat. No. WA3532Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SilevimigCat. No. WA3532U-Blot® Research Grade SigvotatugCat. No. WA3531Request quote
Size: 50ug/100ug
U-Blot® Research Grade SifaroboceptCat. No. WA3530Request quote
Size: 50ug/100ug
U-Blot® Research Grade SifalimumabCat. No. WA3529Request quote
Size: 50ug/100ug
U-Blot® Research Grade SibrotuzumabCat. No. WA3528Request quote
Size: 50ug/100ug
U-Blot® Research Grade SibeprenlimabCat. No. WA3527Request quote
Size: 50ug/100ug
U-Blot® Research Grade SGN-B7H4VCat. No. WA3526Request quote
Size: 50ug/100ug
U-Blot® Research Grade SevirumabCat. No. WA3525Request quote
Size: 50ug/100ug
U-Blot® Research Grade SetrusumabCat. No. WA3524Request quote
Size: 50ug/100ug
U-Blot® Research Grade SetoxaximabCat. No. WA3523Request quote
Size: 50ug/100ug
U-Blot® Research Grade SerrumabCat. No. WA3522Request quote
Size: 50ug/100ug
U-Blot® Research Grade SerplulimabCat. No. WA3521Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598